1. Home
  2. ENOV vs ESBA Comparison

ENOV vs ESBA Comparison

Compare ENOV & ESBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • ESBA
  • Stock Information
  • Founded
  • ENOV 1995
  • ESBA N/A
  • Country
  • ENOV United States
  • ESBA United States
  • Employees
  • ENOV N/A
  • ESBA N/A
  • Industry
  • ENOV Fluid Controls
  • ESBA
  • Sector
  • ENOV Industrials
  • ESBA
  • Exchange
  • ENOV Nasdaq
  • ESBA NYSE
  • Market Cap
  • ENOV 1.7B
  • ESBA 2.0B
  • IPO Year
  • ENOV 2008
  • ESBA 2013
  • Fundamental
  • Price
  • ENOV $33.65
  • ESBA $8.01
  • Analyst Decision
  • ENOV Strong Buy
  • ESBA
  • Analyst Count
  • ENOV 5
  • ESBA 0
  • Target Price
  • ENOV $58.00
  • ESBA N/A
  • AVG Volume (30 Days)
  • ENOV 1.6M
  • ESBA 5.1K
  • Earning Date
  • ENOV 08-06-2025
  • ESBA 01-01-0001
  • Dividend Yield
  • ENOV N/A
  • ESBA 1.75%
  • EPS Growth
  • ENOV N/A
  • ESBA 3.47
  • EPS
  • ENOV N/A
  • ESBA 0.30
  • Revenue
  • ENOV $2,150,191,000.00
  • ESBA $762,039,000.00
  • Revenue This Year
  • ENOV $8.23
  • ESBA N/A
  • Revenue Next Year
  • ENOV $6.18
  • ESBA N/A
  • P/E Ratio
  • ENOV N/A
  • ESBA $26.73
  • Revenue Growth
  • ENOV 18.32
  • ESBA 0.78
  • 52 Week Low
  • ENOV $28.83
  • ESBA $6.39
  • 52 Week High
  • ENOV $49.83
  • ESBA $11.50
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 56.27
  • ESBA 49.42
  • Support Level
  • ENOV $30.84
  • ESBA $7.56
  • Resistance Level
  • ENOV $33.95
  • ESBA $8.75
  • Average True Range (ATR)
  • ENOV 1.15
  • ESBA 0.32
  • MACD
  • ENOV 0.33
  • ESBA -0.08
  • Stochastic Oscillator
  • ENOV 90.53
  • ESBA 43.51

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About ESBA EMPIRE STATE REALTY OP LIM PARTNER

Empire State Realty OP LP is an NYC-focused real estate investment trust (REIT) that owns and operates a portfolio of well-leased, top-of-tier, modernized, amenitized, and well-located office, retail, and multifamily assets, conducts all of its business and owns substantially all of its assets. The firm operates in two segments, Real Estate and Observatory. Through the Real Estate segment, it offers services related to the ownership, management, operation, acquisition, repositioning and disposition of its real estate assets. Under the Observatory segment, it operates the two observatories of the Empire State Building. The company generates maximum revenue from the Real Estate segment.

Share on Social Networks: